BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 86 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,897,000 | -15.4% | 36,073 | -5.2% | 0.01% | -23.1% |
| Q2 2020 | $2,243,000 | -5.8% | 38,035 | -9.7% | 0.01% | -13.3% |
| Q1 2020 | $2,381,000 | -30.9% | 42,102 | -30.4% | 0.02% | -11.8% |
| Q4 2019 | $3,444,000 | +5.4% | 60,492 | -1.0% | 0.02% | 0.0% |
| Q3 2019 | $3,269,000 | -8.6% | 61,090 | +2.0% | 0.02% | -5.6% |
| Q2 2019 | $3,575,000 | -13.2% | 59,884 | -9.4% | 0.02% | -18.2% |
| Q1 2019 | $4,119,000 | +3.4% | 66,097 | +0.5% | 0.02% | -12.0% |
| Q4 2018 | $3,985,000 | -27.7% | 65,768 | -30.2% | 0.02% | -7.4% |
| Q3 2018 | $5,510,000 | +29.1% | 94,206 | -1.0% | 0.03% | +17.4% |
| Q2 2018 | $4,267,000 | -35.9% | 95,130 | -36.7% | 0.02% | -36.1% |
| Q1 2018 | $6,660,000 | +15.1% | 150,217 | +12.5% | 0.04% | +12.5% |
| Q4 2017 | $5,784,000 | -34.3% | 133,493 | -27.9% | 0.03% | -36.0% |
| Q3 2017 | $8,807,000 | -2.4% | 185,142 | +1.6% | 0.05% | -7.4% |
| Q2 2017 | $9,021,000 | -9.1% | 182,206 | +0.6% | 0.05% | -12.9% |
| Q1 2017 | $9,927,000 | -4.0% | 181,167 | -2.4% | 0.06% | -8.8% |
| Q4 2016 | $10,340,000 | +22.4% | 185,652 | +0.4% | 0.07% | +19.3% |
| Q3 2016 | $8,448,000 | +77.9% | 184,998 | +55.6% | 0.06% | +72.7% |
| Q2 2016 | $4,748,000 | – | 118,889 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 73,649 | $3,646,000 | 2.32% |
| Stonepine Capital Management, LLC | 59,878 | $2,965,000 | 1.60% |
| NORTHPOINTE CAPITAL LLC | 109,644 | $5,428,000 | 0.57% |
| Elk Creek Partners, LLC | 145,406 | $7,199,000 | 0.47% |
| TFS CAPITAL LLC | 18,208 | $901,000 | 0.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 161,671 | $8,004,000 | 0.35% |
| Ativo Capital Management LLC | 19,592 | $970,000 | 0.26% |
| Matarin Capital Management, LLC | 57,034 | $2,823,753,000 | 0.26% |
| ISTHMUS PARTNERS, LLC | 16,505 | $817,000 | 0.24% |
| Stanley-Laman Group, Ltd. | 12,546 | $621,000 | 0.17% |